scispace - formally typeset
Open AccessJournal ArticleDOI

Identifying a typology of men who use anabolic androgenic steroids (AAS)

Reads0
Chats0
TLDR
The results of this study demonstrate the need to make information about AAS accessible to the general population and to inform health service providers about variations in motivations and associated risk behaviours.
About
This article is published in International Journal of Drug Policy.The article was published on 2018-05-01 and is currently open access. It has received 76 citations till now. The article focuses on the topics: Population.

read more

Citations
More filters
Journal ArticleDOI

Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy.

TL;DR: There is a convergence of IPED use and supply with diverted medication and 'traditional' recreational substances, and a review of existing harm reduction advice for IPED users that takes into consideration the full range of substances currently being used.
Journal ArticleDOI

Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access

TL;DR: It is indicated that AAS users access a range of sources of information on: how to inject, substance effectiveness, dosages and side effects, suggesting this is the type of information users want.
Journal ArticleDOI

Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires

TL;DR: Health problems, motivations for AAS cessation, and treatment desires among AAS users are described and barriers to treatment may be overcome with an easily accessible service that informs about addiction treatment and facilitates the treatment entry process.
Journal ArticleDOI

"Yay, Another Lady Starting a Log!": Women's Fitness Doping and the Gendered Space of an Online Doping Forum

TL;DR: In this article, the meanings attached to women's use of performance and image enhancing drugs (PIEDs), how fitness doping can be understood in terms of gender and spatial context.
References
More filters
Journal ArticleDOI

The use and reporting of cluster analysis in health psychology: A review

TL;DR: The reporting of cluster analysis was found to be generally unsatisfactory, with many studies failing to provide enough information to allow replication or the evaluation of the quality of the research.
Journal ArticleDOI

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

TL;DR: This scientific statement synthesizes available information on the medical consequences of P ED use, identifies gaps in knowledge, and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
Journal ArticleDOI

Anabolic androgenic steroids: a survey of 500 users.

TL;DR: AAS users in this sample are taking larger doses than previously recorded, with more than half of the respondents using a weekly AAS dose in excess of 1000 mg, and several trends in the nonmedical use of AAS are revealed.
Journal ArticleDOI

A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States

TL;DR: The typical user was a Caucasian, highly-educated, gainfully employed professional approximately 30 years of age, who was earning an above-average income, was not active in organized sports, and whose use was motivated by increases in skeletal muscle mass, strength, and physical attractiveness.
Journal ArticleDOI

Gym and tonic: a profile of 100 male steroid users.

TL;DR: Multiple steroids are combined in megadoses and self administered in a cyclical fashion and skeletal muscle hypertrophy along with acne, striae, and gynaecomastia are frequent physical signs associated with steroid use.
Related Papers (5)
Frequently Asked Questions (11)
Q1. What have the authors contributed in "Identifying a typology of men who use anabolic androgenic steroids (aas)" ?

The use of anabolic androgenic steroids ( AAS ) for muscular gain, performance and image enhancement is not new this paper. 

2than half of the individuals in this group (54.6%) report drinking alcohol 2-4 times a month and one third (32.8%) report binge drinking weekly. 

Participants were identified through service attendance or within gymsand sport settings through a snowball approach where participants were recommended by other participants and gatekeepers. 

Most commonly,individuals in cluster 3 acquire IPEDs from multiple sources (32.9%); more than a quarter (27.7%) report sourcing their IPEDs through a dealer. 

cluster 2 individuals have experienced 1.1 adverse effects related to their AAS use and most commonly report sourcing their AAS through friends (37.3%). 

An understanding of the types of AAS use, and their associated motivations, risk behaviours and vulnerabilities, is important for the development and provision of appropriate policy responses. 

Individuals in cluster 2 are unlikely to use otherIPEDs in addition to AAS (2.9%) and the majority have used two or less injectable AAS in the past 12 months (12.3%). 

They identify certain ‘sets’ of characteristics and behaviours that tend to co-occurand can be used to inform interventions that are tailored to the risk profile of different ‘types’ of drug users. 

The final analytic cohort for this study comprised male participants only for whom a full composite of relevant variables were available(n=611). 

Cluster 4 are theless likely, when compared to cluster 2 (Wellbeing) to state achieving ‘fitness’ as a motivating factor for their AAS use. 

While household surveys suggest lifetime prevalence of AAS use has remained relatively low and stablesince the 1990s, at least in western world countries, there is agreement among scholars that the use of steroids is a growing public health issue {Vinther, 2015}.